Progressive supranuclear palsy is a rare brain condition that gradually affects movement, balance, vision, and thinking, often leading to unexpected falls and difficulty controlling the eyes. Unlike more common disorders, this condition progresses relatively quickly and presents unique challenges for those diagnosed and their families.

Understanding Progressive Supranuclear Palsy

Progressive supranuclear palsy, often called PSP, is a rare brain disorder that affects how a person moves, thinks, speaks, and sees. The term itself tells us about the condition: “progressive” means symptoms worsen over time, “supranuclear” refers to the part of the brain above the nerve control centers, and “palsy” indicates muscle weakness. This disease causes brain cells in specific areas to become damaged and die, particularly in regions that control body movement, balance, eye movement, and coordination.^[1][2]

PSP is also known by another name: Steele-Richardson-Olszewski syndrome, named after the doctors who first officially described it in 1963. However, the earliest known case showing signs consistent with PSP was actually reported in France in 1951.^[3] The condition belongs to a family of disorders called atypical parkinsonism, which means conditions that resemble Parkinson’s disease but have different causes and characteristics.^[2][6]

Epidemiology: How Common Is PSP?

Progressive supranuclear palsy is considered a rare condition, affecting approximately 5 to 7 people out of every 100,000 individuals worldwide. When all types of PSP are considered together, the prevalence increases to about 18 per 100,000. In the United States, this translates to roughly 30,000 people living with the disease. These numbers are likely underestimates because PSP is frequently misdiagnosed as other conditions, particularly Parkinson’s disease or frontotemporal dementia.^[3][7]

The condition typically appears in people between the ages of 60 and 70, though symptoms can occasionally begin as early as the 40s. It very rarely develops before age 40. Men are slightly more likely to develop PSP than women, though the difference is not dramatic. Importantly, no association has been found between PSP and any particular race, geographic location, or occupation, meaning anyone can potentially develop this condition regardless of where they live or what they do for work.^[1][3][7]

When compared to other neurological conditions, PSP is much less common than Parkinson’s disease, which affects about 1 million people in the United States, and Alzheimer’s disease, which affects approximately 7 million Americans. However, PSP is slightly more common than ALS (also known as Lou Gehrig’s disease), though ALS is more widely recognized by the public.^[7]

Causes of Progressive Supranuclear Palsy

Scientists do not fully understand what causes progressive supranuclear palsy, and much about the disease remains mysterious. However, researchers have identified that a protein called tau plays a central role in the condition. Tau is a naturally occurring protein that is essential for healthy brain function. In people with PSP, tau protein accumulates abnormally and forms harmful clumps inside brain cells.^[2][4][5]

In a healthy brain, tau is broken down and recycled before it reaches dangerous levels. In PSP, this normal breakdown process fails to work properly, allowing tau to build up and aggregate within multiple types of brain cells, including neurons and supporting cells. These tau deposits damage and eventually kill the cells, leading to the symptoms of PSP. The amount of abnormal tau and where it accumulates can vary from person to person, which helps explain why symptoms can differ among individuals with the condition.^[4][5]

The condition has been linked to changes in certain genes, but these genetic alterations are not inherited in a traditional sense. This means the risk to other family members, including children or siblings of someone with PSP, is very low. PSP is not considered a hereditary disease that runs in families, and there is no known way to pass it directly from parent to child.^[5]

PSP occurs when brain cells in specific areas deteriorate. The regions most affected include the brainstem, cerebral cortex, cerebellum, and a cluster of cells deep within the brain called the basal ganglia. These areas are responsible for coordinating movement, maintaining balance, controlling eye movements, and managing thinking processes. When these cells are damaged, the various symptoms of PSP emerge.^[1][6]

Risk Factors

Because the exact cause of progressive supranuclear palsy remains unknown, identifying specific risk factors has proven challenging for researchers. Age is the most clearly established risk factor, as PSP predominantly affects people over 60 years old. The condition is extremely rare in people under 40.^[2][7]

Being male slightly increases the likelihood of developing PSP compared to being female, though the difference is modest. Beyond age and sex, no other clear risk factors have been definitively established. Unlike some diseases that have environmental triggers or lifestyle-related causes, PSP does not appear to be linked to occupational exposures, geographic location, dietary habits, or other modifiable factors.^[3][7]

While genetic changes have been associated with PSP, these are not passed down through families in a predictable pattern. The genetic component appears to be related to sporadic mutations rather than inherited genetic predisposition, which is why family members of someone with PSP face a very low risk of developing the condition themselves.^[5]

Symptoms of Progressive Supranuclear Palsy

The symptoms of progressive supranuclear palsy vary considerably from person to person, and they tend to begin gradually before becoming more severe over several years. The pattern and severity of symptoms can differ based on which areas of the brain are most affected by the disease. No two people with PSP will experience exactly the same set or intensity of symptoms.^[2][7]

In about two-thirds of cases, the first symptoms people notice involve problems with balance and walking. Many experience a loss of balance when climbing stairs or walking, which leads to frequent, unexpected falls. These falls often occur backward rather than forward, and they can happen without loss of consciousness. Some people may lunge forward when trying to move or bump into objects and people because of difficulty judging distances and coordinating movements.^[3][4][6]

Eye and vision problems are among the most characteristic symptoms of PSP, though they may not appear until the disease progresses. People with PSP often develop difficulty moving their eyes, particularly looking downward. This makes tasks like reading, eating, or going down stairs challenging and sometimes dangerous. Some people experience slow eye movements, trouble focusing on specific objects, or an inability to look up or down at things. Double vision or blurred vision can occur. The reduced ability to blink leads to dry, irritated eyes and sensitivity to bright light, a condition called photophobia. Many people need to wear sunglasses even indoors to avoid discomfort from lighting.^[1][2][4][6]

Muscle stiffness, especially in the neck and trunk, is common in PSP. This stiffness affects mobility and causes people to move in a rigid, block-like manner when walking, turning, or sitting. The stiffness tends to be more pronounced in the trunk and neck than in the arms and legs, which differs from Parkinson’s disease. General slowing of movement, called bradykinesia, means that daily activities like eating, dressing, and bathing take much longer than they used to.^[2][4]

Speech and swallowing difficulties are frequent problems as PSP progresses. Speech may become slower, quieter, slurred, or monotone, making it difficult for others to understand. Swallowing problems, known as dysphagia, can lead to choking, gagging, and a serious condition called aspiration pneumonia, which occurs when food or liquid enters the lungs instead of the stomach.^[1][2][6]

Changes in thinking, mood, and behavior are also part of PSP. Many people experience what doctors call apathy, which is a loss of interest or motivation to engage in activities they once enjoyed. Forgetfulness, slowness of thought, difficulty making decisions, problems with abstract thinking, and poor judgment are common cognitive symptoms. Some people become irritable, depressed, anxious, or display sudden outbursts of laughing, crying, or anger for no apparent reason. Personality changes and impulsive behavior can strain relationships with family and friends.^[2][6][7]

About one in five people with PSP first notice cognitive or behavioral symptoms rather than movement problems. Sleep disturbances, including insomnia and a condition called REM sleep behavior disorder, can affect quality of life. Many people develop a distinctive facial appearance, with decreased facial expressions creating what looks like a mask-like or wide-eyed, staring expression that can make them appear surprised or astonished.^[2][3][4]

Prevention

Currently, there are no known methods to prevent progressive supranuclear palsy. Because scientists do not fully understand what triggers the condition or why tau protein accumulates abnormally in the brain, no preventive measures, lifestyle changes, dietary modifications, or screening tests have been proven effective at reducing the risk of developing PSP.^[2]

The lack of clear environmental or behavioral risk factors means that there are no specific actions people can take to lower their chances of developing the disease. Unlike some conditions that can be prevented through vaccination, avoiding certain exposures, or adopting healthy habits, PSP appears to occur sporadically without identifiable triggers.^[3]

However, for those already diagnosed with PSP or at risk of falls due to early symptoms, certain precautions can help prevent injury and complications. Early evaluation by physical therapists can help identify fall risks and provide strategies to improve safety. Making home modifications, such as removing loose rugs, improving lighting, installing grab bars in bathrooms, and clearing walkways, can reduce the risk of dangerous falls that could lead to head injuries or broken bones.^[9]

Pathophysiology: What Happens in the Body

Progressive supranuclear palsy involves complex changes in the brain that disrupt normal body functions. The disease is classified as a neurodegenerative disorder, meaning brain cells gradually deteriorate and die over time. PSP specifically belongs to a group of conditions called tauopathies because of the central role of tau protein in the disease process.^[2][3]

In healthy brain cells, tau protein helps maintain the structure and transport system within neurons. It normally exists in a balanced state and is regulated by the cell. In PSP, tau becomes chemically altered and aggregates into abnormal clumps or tangles inside brain cells. These aggregates are specifically composed of what scientists call 4-repeat tau. The buildup of these tau clumps disrupts the normal function of brain cells, eventually causing them to malfunction and die.^[3][4]

The brain regions most severely affected by cell death in PSP include the brainstem, which controls many automatic functions and connects the brain to the spinal cord; the basal ganglia, deep brain structures involved in coordinating movement; the cerebral cortex, which manages higher thinking processes; and the cerebellum, which helps with balance and coordination. As cells in these areas die, the affected brain regions shrink, which can sometimes be seen on imaging tests like MRI scans.^[1][6]

The death of brain cells in specific locations produces the characteristic symptoms of PSP. When cells controlling eye movement die, people lose the ability to move their eyes normally. When cells in areas managing balance are destroyed, frequent falls result. The loss of cells involved in muscle control causes stiffness and slowness. Damage to regions handling cognitive functions leads to thinking problems and personality changes.^[2][6]

Unlike Parkinson’s disease, where the primary problem is loss of dopamine-producing cells, PSP involves a broader pattern of damage affecting multiple brain regions and cell types. This explains why medications that work for Parkinson’s disease, which primarily increase dopamine levels, are much less effective or completely ineffective for PSP. The widespread nature of the damage also explains why PSP typically progresses faster than Parkinson’s disease.^[2][6]

Most people with PSP develop severe disability within three to five years after symptoms begin. The disease usually worsens rapidly, though the exact rate varies among individuals. PSP can lead to serious complications including pneumonia from aspiration of food or liquid into the lungs, choking from swallowing difficulties, and severe head injuries from falls. These complications often become life-threatening as the disease progresses. The average survival time after diagnosis is typically seven to ten years, though this can vary.^[6][12]